Global Insomnia Pharmacological Treatment Market Insights, Forecast to 2025

2018-12-05 / 3900.00 / Pharma & Healthcare / 111 Pages

Description

In 2017, the global Insomnia Pharmacological Treatment market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Insomnia Pharmacological Treatment market based on company, product type, application and key regions.

This report studies the global market size of Insomnia Pharmacological Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insomnia Pharmacological Treatment in these regions.
This research report categorizes the global Insomnia Pharmacological Treatment market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Insomnia Pharmacological Treatment include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Insomnia Pharmacological Treatment include
Eisai, Co. Ltd. (Japan)
Merck & Co., Inc. (U.S.)
Meda Consumer Healthcare Inc. (U.S.)
Pfizer, Inc. (U.S.)
Sanofi (France)
Takeda Pharmaceutical Company Ltd. (Japan)
Pernix Therapeutics (U.S.)
Purdue Pharma L.P. (U.S.)

Market Size Split by Type
Prescription Sleep Aids
Over-the-Counter Sleep Aids
Market Size Split by Application
Homecare
Clinic
Hospital

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Insomnia Pharmacological Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Insomnia Pharmacological Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Insomnia Pharmacological Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Insomnia Pharmacological Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Insomnia Pharmacological Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Insomnia Pharmacological Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insomnia Pharmacological Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Study Coverage
1.1 Insomnia Pharmacological Treatment Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type
1.4.2 Prescription Sleep Aids
1.4.3 Over-the-Counter Sleep Aids
1.5 Market by Application
1.5.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Application
1.5.2 Homecare
1.5.3 Clinic
1.5.4 Hospital
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Insomnia Pharmacological Treatment Market Size
2.1.1 Global Insomnia Pharmacological Treatment Revenue 2016-2025
2.1.2 Global Insomnia Pharmacological Treatment Sales 2016-2025
2.2 Insomnia Pharmacological Treatment Growth Rate by Regions
2.2.1 Global Insomnia Pharmacological Treatment Sales by Regions
2.2.2 Global Insomnia Pharmacological Treatment Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Insomnia Pharmacological Treatment Sales by Manufacturers
3.1.1 Insomnia Pharmacological Treatment Sales by Manufacturers
3.1.2 Insomnia Pharmacological Treatment Sales Market Share by Manufacturers
3.1.3 Global Insomnia Pharmacological Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Insomnia Pharmacological Treatment Revenue by Manufacturers
3.2.1 Insomnia Pharmacological Treatment Revenue by Manufacturers (2016-2018)
3.2.2 Insomnia Pharmacological Treatment Revenue Share by Manufacturers (2016-2018)
3.3 Insomnia Pharmacological Treatment Price by Manufacturers
3.4 Insomnia Pharmacological Treatment Manufacturing Base Distribution, Product Types
3.4.1 Insomnia Pharmacological Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insomnia Pharmacological Treatment Product Category
3.4.3 Date of International Manufacturers Enter into Insomnia Pharmacological Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Insomnia Pharmacological Treatment Sales by Type
4.2 Global Insomnia Pharmacological Treatment Revenue by Type
4.3 Insomnia Pharmacological Treatment Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Insomnia Pharmacological Treatment Breakdown Data by Application

6 North America
6.1 North America Insomnia Pharmacological Treatment by Countries
6.1.1 North America Insomnia Pharmacological Treatment Sales by Countries
6.1.2 North America Insomnia Pharmacological Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Insomnia Pharmacological Treatment by Type
6.3 North America Insomnia Pharmacological Treatment by Application
6.4 North America Insomnia Pharmacological Treatment by Company

7 Europe
7.1 Europe Insomnia Pharmacological Treatment by Countries
7.1.1 Europe Insomnia Pharmacological Treatment Sales by Countries
7.1.2 Europe Insomnia Pharmacological Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insomnia Pharmacological Treatment by Type
7.3 Europe Insomnia Pharmacological Treatment by Application
7.4 Europe Insomnia Pharmacological Treatment by Company

8 Asia Pacific
8.1 Asia Pacific Insomnia Pharmacological Treatment by Countries
8.1.1 Asia Pacific Insomnia Pharmacological Treatment Sales by Countries
8.1.2 Asia Pacific Insomnia Pharmacological Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Insomnia Pharmacological Treatment by Type
8.3 Asia Pacific Insomnia Pharmacological Treatment by Application
8.4 Asia Pacific Insomnia Pharmacological Treatment by Company

9 Central & South America
9.1 Central & South America Insomnia Pharmacological Treatment by Countries
9.1.1 Central & South America Insomnia Pharmacological Treatment Sales by Countries
9.1.2 Central & South America Insomnia Pharmacological Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Insomnia Pharmacological Treatment by Type
9.3 Central & South America Insomnia Pharmacological Treatment by Application
9.4 Central & South America Insomnia Pharmacological Treatment by Company

10 Middle East and Africa
10.1 Middle East and Africa Insomnia Pharmacological Treatment by Countries
10.1.1 Middle East and Africa Insomnia Pharmacological Treatment Sales by Countries
10.1.2 Middle East and Africa Insomnia Pharmacological Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Insomnia Pharmacological Treatment by Type
10.3 Middle East and Africa Insomnia Pharmacological Treatment by Application
10.4 Middle East and Africa Insomnia Pharmacological Treatment by Company

11 Company Profiles
11.1 Eisai, Co. Ltd. (Japan)
11.1.1 Eisai, Co. Ltd. (Japan) Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Insomnia Pharmacological Treatment
11.1.4 Insomnia Pharmacological Treatment Product Description
11.1.5 Recent Development
11.2 Merck & Co., Inc. (U.S.)
11.2.1 Merck & Co., Inc. (U.S.) Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Insomnia Pharmacological Treatment
11.2.4 Insomnia Pharmacological Treatment Product Description
11.2.5 Recent Development
11.3 Meda Consumer Healthcare Inc. (U.S.)
11.3.1 Meda Consumer Healthcare Inc. (U.S.) Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Insomnia Pharmacological Treatment
11.3.4 Insomnia Pharmacological Treatment Product Description
11.3.5 Recent Development
11.4 Pfizer, Inc. (U.S.)
11.4.1 Pfizer, Inc. (U.S.) Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Insomnia Pharmacological Treatment
11.4.4 Insomnia Pharmacological Treatment Product Description
11.4.5 Recent Development
11.5 Sanofi (France)
11.5.1 Sanofi (France) Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Insomnia Pharmacological Treatment
11.5.4 Insomnia Pharmacological Treatment Product Description
11.5.5 Recent Development
11.6 Takeda Pharmaceutical Company Ltd. (Japan)
11.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Insomnia Pharmacological Treatment
11.6.4 Insomnia Pharmacological Treatment Product Description
11.6.5 Recent Development
11.7 Pernix Therapeutics (U.S.)
11.7.1 Pernix Therapeutics (U.S.) Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Insomnia Pharmacological Treatment
11.7.4 Insomnia Pharmacological Treatment Product Description
11.7.5 Recent Development
11.8 Purdue Pharma L.P. (U.S.)
11.8.1 Purdue Pharma L.P. (U.S.) Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Insomnia Pharmacological Treatment
11.8.4 Insomnia Pharmacological Treatment Product Description
11.8.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Insomnia Pharmacological Treatment Raw Material
13.1.2 Insomnia Pharmacological Treatment Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Picture of Insomnia Pharmacological Treatment
Figure Global Insomnia Pharmacological Treatment Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Insomnia Pharmacological Treatment Production Market Share by Types (Product Category) in 2017
Figure Prescription Sleep Aids Product Picture
Table Major Manufacturers of Prescription Sleep Aids
Figure Over-the-Counter Sleep Aids Product Picture
Table Major Manufacturers of Over-the-Counter Sleep Aids
Table Global Insomnia Pharmacological Treatment Market Size Growth Rate by Application 2018-2025 (K Pcs)
Figure Homecare
Figure Clinic
Figure Hospital
Figure Insomnia Pharmacological Treatment Report Years Considered
Figure Global Insomnia Pharmacological Treatment Market Size 2016-2025 (Million US$)
Figure Global Insomnia Pharmacological Treatment Sales 2016-2025 (K Pcs)
Table Global Insomnia Pharmacological Treatment Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
Table Global Insomnia Pharmacological Treatment Sales by Regions 2016-2025 (K Pcs)
Table Global Insomnia Pharmacological Treatment Sales Market Share by Regions 2016-2025
Figure Global Insomnia Pharmacological Treatment Sales Market Share by Regions 2016-2025
Figure 2017 Global Insomnia Pharmacological Treatment Sales Market Share by Regions
Table Global Insomnia Pharmacological Treatment Revenue by Regions 2016-2025 (Million US$)
Table Global Insomnia Pharmacological Treatment Revenue Market Share by Regions 2016-2025
Figure Global Insomnia Pharmacological Treatment Revenue Market Share by Regions 2016-2025
Figure 2017 Global Insomnia Pharmacological Treatment Revenue Market Share by Regions
Table Global Insomnia Pharmacological Treatment Sales by Manufacturers (2016-2018) (K Pcs)
Table Global Insomnia Pharmacological Treatment Sales Share by Manufacturers (2016-2018)
Figure Global Insomnia Pharmacological Treatment Sales Share by Manufacturers in 2017
Table Insomnia Pharmacological Treatment Revenue by Manufacturers (2016-2018) (Million US$)
Table Insomnia Pharmacological Treatment Revenue Share by Manufacturers (2016-2018)
Figure Insomnia Pharmacological Treatment Value Share by Manufacturers in 2017
Table Global Insomnia Pharmacological Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Insomnia Pharmacological Treatment Price (2016-2018) (USD/Pcs)
Table Insomnia Pharmacological Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Insomnia Pharmacological Treatment Product Category
Table Date of International Manufacturers Enter into Insomnia Pharmacological Treatment Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Insomnia Pharmacological Treatment Sales by Type (2016-2025) (K Pcs)
Table Global Insomnia Pharmacological Treatment Sales Share by Type (2016-2025)
Figure Global Insomnia Pharmacological Treatment Sales Market Share by Type (2016-2025)
Figure Global Insomnia Pharmacological Treatment Sales Market Share by Type in 2017
Table Global Insomnia Pharmacological Treatment Revenue by Type (2016-2025) (Million US$)
Table Global Insomnia Pharmacological Treatment Revenue Share by Type (2016-2025)
Figure Global Insomnia Pharmacological Treatment Revenue Market Share by Type (2016-2025)
Figure Global Insomnia Pharmacological Treatment Revenue Market Share by Type in 2017
Table Insomnia Pharmacological Treatment Price by Type 2013-2018 (USD/Pcs)
Table Global Insomnia Pharmacological Treatment Sales by Application (2016-2025) (K Pcs)
Table Global Insomnia Pharmacological Treatment Sales Share by Application (2016-2025)
Figure Global Sales Insomnia Pharmacological Treatment Market Share by Application (2016-2025)
Figure Global Sales Insomnia Pharmacological Treatment Market Share by Application (2016-2025)
Figure North America Insomnia Pharmacological Treatment Sales Growth Rate 2016-2025 (K Pcs)
Figure North America Insomnia Pharmacological Treatment Revenue Growth Rate 2016-2025 (Million US$)
Table North America Insomnia Pharmacological Treatment Sales by Countries (2016-2025) (K Pcs)
Table North America Insomnia Pharmacological Treatment Sales Market Share by Countries (2016-2025)
Figure 2017 North America Insomnia Pharmacological Treatment Sales Market Share by Countries
Table North America Insomnia Pharmacological Treatment Revenue by Countries (2016-2025) (Million US$)
Table North America Insomnia Pharmacological Treatment Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Insomnia Pharmacological Treatment Revenue Market Share by Countries
Figure United States Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure United States Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Canada Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Mexico Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Table North America Insomnia Pharmacological Treatment Sales by Type (2016-2025) (K Pcs)
Table North America Insomnia Pharmacological Treatment Sales Market Share by Type (2016-2025)
Figure 2017 North America Insomnia Pharmacological Treatment Market Share by Type
Table North America Insomnia Pharmacological Treatment Sales by Application (2016-2025) (K Pcs)
Table North America Insomnia Pharmacological Treatment Sales Market Share by Application (2016-2025)
Figure 2017 North America Insomnia Pharmacological Treatment Market Share by Application
Table North America Insomnia Pharmacological Treatment Sales by Company (2016-2018) (K Pcs)
Table North America Insomnia Pharmacological Treatment Sales Market Share by Company (2016-2018)
Figure North America Insomnia Pharmacological Treatment Sales Market Share by Company in 2017
Figure Europe Insomnia Pharmacological Treatment Sales Growth Rate 2016-2025 (K Pcs)
Figure Europe Insomnia Pharmacological Treatment Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Insomnia Pharmacological Treatment Sales by Countries (2016-2025) (K Pcs)
Table Europe Insomnia Pharmacological Treatment Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Insomnia Pharmacological Treatment Sales Market Share by Countries
Table Europe Insomnia Pharmacological Treatment Revenue by Countries (2016-2025) (Million US$)
Table Europe Insomnia Pharmacological Treatment Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Insomnia Pharmacological Treatment Revenue Market Share by Countries
Figure Germany Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Germany Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (K Pcs)
Figure France Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure France Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (K Pcs)
Figure UK Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure UK Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Italy Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Russia Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Insomnia Pharmacological Treatment Sales by Type (2016-2025) (K Pcs)
Table Europe Insomnia Pharmacological Treatment Sales Market Share by Type (2016-2025)
Figure 2017 Europe Insomnia Pharmacological Treatment Market Share by Type
Table Europe Insomnia Pharmacological Treatment Sales by Application (2016-2025) (K Pcs)
Table Europe Insomnia Pharmacological Treatment Sales Market Share by Application (2016-2025)
Figure 2017 Europe Insomnia Pharmacological Treatment Market Share by Application
Table Europe Insomnia Pharmacological Treatment Sales by Company (2016-2018) (K Pcs)
Table Europe Insomnia Pharmacological Treatment Sales Market Share by Company (2016-2018)
Figure Europe Insomnia Pharmacological Treatment Sales Market Share by Company in 2017
Figure Asia Pacific Insomnia Pharmacological Treatment Sales Growth Rate 2016-2025 (K Pcs)
Figure Asia Pacific Insomnia Pharmacological Treatment Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Insomnia Pharmacological Treatment Sales by Countries (2016-2025) (K Pcs)
Table Asia Pacific Insomnia Pharmacological Treatment Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Insomnia Pharmacological Treatment Sales Market Share by Countries
Table Asia Pacific Insomnia Pharmacological Treatment Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Insomnia Pharmacological Treatment Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Insomnia Pharmacological Treatment Revenue Market Share by Countries
Figure China Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure China Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Japan Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Korea Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure India Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure India Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Australia Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Indonesia Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Malaysia Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Philippines Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Thailand Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Vietnam Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Singapore Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Insomnia Pharmacological Treatment Sales by Type (2016-2025) (K Pcs)
Table Asia Pacific Insomnia Pharmacological Treatment Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Insomnia Pharmacological Treatment Market Share by Type
Table Asia Pacific Insomnia Pharmacological Treatment Sales by Application (2016-2025) (K Pcs)
Table Asia Pacific Insomnia Pharmacological Treatment Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Insomnia Pharmacological Treatment Market Share by Application
Table Asia Pacific Insomnia Pharmacological Treatment Sales by Company (2016-2018) (K Pcs)
Table Asia Pacific Insomnia Pharmacological Treatment Sales Market Share by Company (2016-2018)
Figure Asia Pacific Insomnia Pharmacological Treatment Sales Market Share by Company in 2017
Figure Central & South America Insomnia Pharmacological Treatment Sales Growth Rate 2016-2025 (K Pcs)
Figure Central & South America Insomnia Pharmacological Treatment Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Insomnia Pharmacological Treatment Sales by Countries (2016-2025) (K Pcs)
Table Central & South America Insomnia Pharmacological Treatment Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Insomnia Pharmacological Treatment Sales Market Share by Countries
Table Central & South America Insomnia Pharmacological Treatment Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Insomnia Pharmacological Treatment Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Insomnia Pharmacological Treatment Revenue Market Share by Countries
Figure Brazil Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Brazil Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Argentina Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Insomnia Pharmacological Treatment Sales by Type (2016-2025) (K Pcs)
Table Central & South America Insomnia Pharmacological Treatment Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Insomnia Pharmacological Treatment Market Share by Type
Table Central & South America Insomnia Pharmacological Treatment Sales by Application (2016-2025) (K Pcs)
Table Central & South America Insomnia Pharmacological Treatment Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Insomnia Pharmacological Treatment Market Share by Application
Table Central & South America Insomnia Pharmacological Treatment Sales by Company (2016-2018) (K Pcs)
Table Central & South America Insomnia Pharmacological Treatment Sales Market Share by Company (2016-2018)
Figure Central & South America Insomnia Pharmacological Treatment Sales Market Share by Company in 2017
Figure Middle East and Africa Insomnia Pharmacological Treatment Sales Growth Rate 2016-2025 (K Pcs)
Figure Middle East and Africa Insomnia Pharmacological Treatment Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Insomnia Pharmacological Treatment Sales by Countries (2016-2025) (K Pcs)
Table Middle East and Africa Insomnia Pharmacological Treatment Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Insomnia Pharmacological Treatment Sales Market Share by Countries
Table Middle East and Africa Insomnia Pharmacological Treatment Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Insomnia Pharmacological Treatment Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Insomnia Pharmacological Treatment Revenue Market Share by Countries
Figure GCC Countries Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure GCC Countries Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Turkey Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure Egypt Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Insomnia Pharmacological Treatment Sales Growth Rate (2016-2025) (K Pcs)
Figure South Africa Insomnia Pharmacological Treatment Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Insomnia Pharmacological Treatment Sales by Type (2016-2025) (K Pcs)
Table Middle East and Africa Insomnia Pharmacological Treatment Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Insomnia Pharmacological Treatment Market Share by Type
Table Middle East and Africa Insomnia Pharmacological Treatment Sales by Application (2016-2025) (K Pcs)
Table Middle East and Africa Insomnia Pharmacological Treatment Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Insomnia Pharmacological Treatment Market Share by Application
Table Middle East and Africa Insomnia Pharmacological Treatment Sales by Company (2016-2018) (K Pcs)
Table Middle East and Africa Insomnia Pharmacological Treatment Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Insomnia Pharmacological Treatment Sales Market Share by Company in 2017
Table Eisai, Co. Ltd. (Japan) Company Details
Table Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Eisai, Co. Ltd. (Japan) Recent Development
Table Merck & Co., Inc. (U.S.) Company Details
Table Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Merck & Co., Inc. (U.S.) Recent Development
Table Meda Consumer Healthcare Inc. (U.S.) Company Details
Table Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Meda Consumer Healthcare Inc. (U.S.) Recent Development
Table Pfizer, Inc. (U.S.) Company Details
Table Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Pfizer, Inc. (U.S.) Recent Development
Table Sanofi (France) Company Details
Table Sanofi (France) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Sanofi (France) Recent Development
Table Takeda Pharmaceutical Company Ltd. (Japan) Company Details
Table Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Takeda Pharmaceutical Company Ltd. (Japan) Recent Development
Table Pernix Therapeutics (U.S.) Company Details
Table Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Pernix Therapeutics (U.S.) Recent Development
Table Purdue Pharma L.P. (U.S.) Company Details
Table Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Purdue Pharma L.P. (U.S.) Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Insomnia Pharmacological Treatment Value Chain
Table Typical Suppliers of Key Insomnia Pharmacological Treatment Raw Material
Table Insomnia Pharmacological Treatment Customers List
Table Insomnia Pharmacological Treatment Sales Channels
Table Insomnia Pharmacological Treatment Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory